PLASMA DELTA-9-TETRAHYDROCANNABINOL CONCENTRATIONS AND CLINICAL EFFECTS AFTER ORAL AND INTRAVENOUS ADMINISTRATION AND SMOKING

被引:357
作者
OHLSSON, A
LINDGREN, JE
WAHLEN, A
AGURELL, S
HOLLISTER, LE
GILLESPIE, HK
机构
[1] VET ADM HOSP,MED CTR,PALO ALTO,CA 94304
[2] KAROLINSKA INST,DEPT PHARMACOL,S-10401 STOCKHOLM 60,SWEDEN
[3] ASTRA LAKEMEDEL AB,S-15185 SODERTALJE,SWEDEN
关键词
D O I
10.1038/clpt.1980.181
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:409 / 416
页数:8
相关论文
共 21 条
[1]  
AGURELL S, 1976, PHARM MARIHUANA, P49
[2]  
AGURELL S, 1979, MARIHUANA BIOL EFFEC, P3
[3]  
DOMINO EF, 1974, CLIN PHARMACOL THER, V15, P514
[4]   STABILITY OF TETRAHYDROCANNABINOLS .2. [J].
GARRETT, ER ;
GOUYETTE, AJ ;
ROSEBOOM, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (01) :27-32
[5]   PHARMACOKINETICS OF DELTA-9-TETRAHYDROCANNABINOL IN DOGS [J].
GARRETT, ER ;
HUNT, CA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (03) :395-407
[6]  
HOLLISTER LE, 1973, CLIN PHARMACOL THER, V14, P353
[7]   STRUCTURE-ACTIVITY-RELATIONSHIPS IN MAN OF CANNABIS CONSTITUENTS, AND HOMOLOGS AND METABOLITES OF DELTA-9-TETRAHYDROCANNABINOL [J].
HOLLISTER, LE .
PHARMACOLOGY, 1974, 11 (01) :3-11
[8]  
HOLLISTER LE, 1975, CLIN PHARMACOL THER, V18, P80
[9]  
HOSKO MJ, 1973, CLIN PHARMACOL THER, V14, P344
[10]   DELTA-9-TETRAHYDROCANNABINOL - TEMPORAL CORRELATION OF PSYCHOLOGIC EFFECTS AND BLOOD LEVELS AFTER VARIOUS ROUTES OF ADMINISTRATION [J].
LEMBERGER, L ;
WEISS, JL ;
WATANABE, AM ;
WYATT, RJ ;
CARDON, PV ;
GALANTER, IM .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (13) :685-+